V

M

VELTEN , Michel

Last name: VELTEN

First name: Michel

May 2018 (v1)

Journal article

Metadata-only

Efficacy of anthracycline/taxane-based neo-adjuvant chemotherapy on triple-negative breast cancer in BRCA1 / BRCA2 mutation carriers

Bignon, Lucie Fricker, Jean-Pierre Noguès, Catherine

This study aims to estimate the pathologic complete response (pCR) rate after neo-adjuvant chemotherapy and to compare disease-free survival (DFS) and overall survival (OS) between pCR and non-pCR groups of patients with triple-negative breast cancer (TNBC) and deleterious BRCA1 or BRCA2 mutation. We carried out a retrospective analysis of 53...

Uploaded on: December 4, 2022
February 21, 2019 (v1)

Journal article

Metadata-only

The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME)

Pérol, David Robain, Mathieu Arveux, Patrick

Purpose The currently ongoing Epidemiological Strategy and Medical Economics (ESME) research programme aims at centralising real-life data on oncology care for epidemiological research purposes. We draw on results from the metastatic breast cancer (MBC) cohort to illustrate the methodology used for data collection in the ESME research...

Uploaded on: December 4, 2022